Literature DB >> 641217

Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.

P V Luoma, P A Kujala, H J Juustila, J T Takkunen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 641217     DOI： 10.1002/j.1552-4604.1978.tb02449.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  6 in total

1.  Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation.

Authors:  H Nakazawa; N Ishikawa; J Noh; T Sugimoto; M Yoshimoto; T Yashiro; O Ozaki; K Ito
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Efficacy of intravenous disopyramide in acute cardiac arrhythmias.

Authors:  M De Backer; E Stoupel; R J Kahn
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

3.  Plasma concentration of disopyramide given as capsules and controlled release tablets.

Authors:  K Arnman; C Graffner; L Rikner; L Ryden; L Voog
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.

Authors:  K K Sethi; S Jaishankar; M Khalilullah; M P Gupta
Journal:  Br Heart J       Date:  1983-06

5.  Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.

Authors:  J Camm; D Ward; R Spurrell
Journal:  Br Heart J       Date:  1980-09

6.  The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.

Authors:  J Camm; D Ward; R A Spurrell
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.